)
Ashley Magargee
CEO
Genentech
In January 2024, Ashley Magargee was appointed chief executive officer of Genentech, a member of the Roche Group, and joined its Board of Directors. As CEO, she provides strategic leadership, cultivates a vibrant culture, and focuses on bringing life-changing medicines to patients.
Ashley has spent two decades at Genentech and Roche, holding numerous global leadership roles. Before becoming CEO, she was head of the Commercial Portfolio Organization, where she successfully launched groundbreaking medicines and expanded the company’s presence in several therapeutic areas. Her career also includes shaping the company's digital engagement strategy and leading commercial operations for Roche in Singapore and Brunei.
She started her career on Capitol Hill, where she focused on health policy, and later as an assistant principal in Harlem which laid the groundwork for her dedication to leveraging innovation to improve healthcare. She also serves on the Board of Directors for the Pharmaceutical Research and Manufacturers of America. She graduated from Princeton University and earned her MBA from Harvard University.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}